Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATURAL CAPS vs BAFNA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATURAL CAPS BAFNA PHARMA NATURAL CAPS/
BAFNA PHARMA
 
P/E (TTM) x 39.4 16.1 244.6% View Chart
P/BV x 2.3 2.5 93.9% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 NATURAL CAPS   BAFNA PHARMA
EQUITY SHARE DATA
    NATURAL CAPS
Mar-23
BAFNA PHARMA
Mar-23
NATURAL CAPS/
BAFNA PHARMA
5-Yr Chart
Click to enlarge
High Rs679141 481.6%   
Low Rs37479 476.4%   
Sales per share (Unadj.) Rs184.448.8 378.1%  
Earnings per share (Unadj.) Rs19.74.8 411.7%  
Cash flow per share (Unadj.) Rs27.47.0 389.4%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.20-  
Book value per share (Unadj.) Rs131.831.0 424.5%  
Shares outstanding (eoy) m9.3523.66 39.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.92.3 126.9%   
Avg P/E ratio x26.722.9 116.5%  
P/CF ratio (eoy) x19.215.6 123.2%  
Price / Book Value ratio x4.03.5 113.0%  
Dividend payout %5.10-   
Avg Mkt Cap Rs m4,9222,596 189.6%   
No. of employees `000NANA-   
Total wages/salary Rs m95159 60.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,7241,154 149.4%  
Other income Rs m1633 49.4%   
Total revenues Rs m1,7401,186 146.7%   
Gross profit Rs m343157 218.3%  
Depreciation Rs m7253 135.1%   
Interest Rs m3720 182.9%   
Profit before tax Rs m250116 215.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m653 2,355.0%   
Profit after tax Rs m184113 162.7%  
Gross profit margin %19.913.6 146.1%  
Effective tax rate %26.22.4 1,093.3%   
Net profit margin %10.79.8 108.9%  
BALANCE SHEET DATA
Current assets Rs m1,015873 116.3%   
Current liabilities Rs m669465 144.0%   
Net working cap to sales %20.135.4 56.6%  
Current ratio x1.51.9 80.7%  
Inventory Days Days62 344.2%  
Debtors Days Days1,1041,302 84.8%  
Net fixed assets Rs m1,873423 443.0%   
Share capital Rs m93237 39.2%   
"Free" reserves Rs m1,140498 228.8%   
Net worth Rs m1,232735 167.8%   
Long term debt Rs m70484 834.7%   
Total assets Rs m2,8881,296 222.8%  
Interest coverage x7.76.7 115.0%   
Debt to equity ratio x0.60.1 497.5%  
Sales to assets ratio x0.60.9 67.1%   
Return on assets %7.710.3 74.4%  
Return on equity %15.015.4 97.0%  
Return on capital %14.816.7 89.0%  
Exports to sales %15.00-   
Imports to sales %07.9 0.0%   
Exports (fob) Rs m258NA-   
Imports (cif) Rs mNA91 0.0%   
Fx inflow Rs m258885 29.2%   
Fx outflow Rs m14091 154.9%   
Net fx Rs m118794 14.8%   
CASH FLOW
From Operations Rs m17250 347.6%  
From Investments Rs m-1,046-75 1,396.4%  
From Financial Activity Rs m875102 859.7%  
Net Cashflow Rs m176 1.0%  

Share Holding

Indian Promoters % 56.6 88.4 64.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.3 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 43.4 11.6 375.5%  
Shareholders   11,399 7,367 154.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATURAL CAPS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NATURAL CAPS vs BAFNA PHARM.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NATURAL CAPS vs BAFNA PHARM. Share Price Performance

Period NATURAL CAPS BAFNA PHARM. S&P BSE HEALTHCARE
1-Day 0.08% -1.07% 1.18%
1-Month -7.45% -11.71% -0.75%
1-Year -21.24% -4.18% 61.82%
3-Year CAGR 50.09% -19.05% 18.16%
5-Year CAGR 42.23% 47.58% 19.79%

* Compound Annual Growth Rate

Here are more details on the NATURAL CAPS share price and the BAFNA PHARM. share price.

Moving on to shareholding structures...

The promoters of NATURAL CAPS hold a 56.6% stake in the company. In case of BAFNA PHARM. the stake stands at 88.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NATURAL CAPS and the shareholding pattern of BAFNA PHARM..

Finally, a word on dividends...

In the most recent financial year, NATURAL CAPS paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 5.1%.

BAFNA PHARM. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of NATURAL CAPS, and the dividend history of BAFNA PHARM..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.